All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Capstone Therapeutics Corp., of Tempe, Ariz., and Lipimetix Development Inc., Capstone's 60 percent-owned joint venture (JV), said its lenders informed the companies they would not exercise their option to extend the exclusive due diligence period through March 31, by loaning Capstone a second $1 million, under the terms of the previously reported securities purchase agreement.